ALZHEIMER'S DISEASE PSYCHOSIS
Clinical trials for ALZHEIMER'S DISEASE PSYCHOSIS explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMER'S DISEASE PSYCHOSIS trials appear
Sign up with your email to follow new studies for ALZHEIMER'S DISEASE PSYCHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for Alzheimer's psychosis: 52-Week safety trial launches
Disease control ENROLLING_BY_INVITATIONThis study tests the long-term safety of an experimental drug, ACP-204, for people with Alzheimer's disease who also have psychosis (hallucinations or delusions). About 752 adults aged 55 to 95 who completed a prior ACP-204 study will take the drug for 52 weeks. Researchers will …
Matched conditions: ALZHEIMER'S DISEASE PSYCHOSIS
Phase: PHASE3 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Disease control
Last updated May 26, 2026 11:34 UTC
-
New drug LY03020: does food change how it works?
Knowledge-focused OngoingThis study looks at whether eating food changes how the body absorbs a new medicine called LY03020, which is being developed for schizophrenia and Alzheimer's-related psychosis. Sixteen healthy adults will take the drug once with food and once without, and researchers will measur…
Matched conditions: ALZHEIMER'S DISEASE PSYCHOSIS
Phase: PHASE1 • Sponsor: Luye Pharma Group Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 11:33 UTC